Literature DB >> 25185601

Transforming growth factor β1 and extracellular matrix protease expression in the uterosacral ligaments of patients with and without pelvic organ prolapse.

Ava Leegant1, Lisa C Zuckerwise, Keith Downing, Jurriaan Brouwer-Visser, Changcheng Zhu, Maria Jose Cossio, Felix Strube, Xianhong Xie, Erika Banks, Gloria S Huang.   

Abstract

OBJECTIVES: This study was undertaken to evaluate the expression of transforming growth factor β1 (TGF-β1) and matrix metalloproteinase 9 (MMP-9), key regulators of the extracellular matrix composition, in the uterosacral ligaments (USLs) of women with pelvic organ prolapse (POP) compared with controls.
METHODS: Under an institutional review board approval, USL samples were obtained from women undergoing vaginal hysterectomy for stage 2 or greater POP (cases, n = 21) and from women without POP undergoing vaginal hysterectomy for benign indications (controls, n = 19). Hematoxylin and eosin and trichrome staining were performed on the USL sections, and the distribution of smooth muscle and fibrous tissue were quantified. Immunohistochemical staining was performed using anti-TGF-β1 and anti-MMP-9 antibodies. The expressions of TGF-β1 and MMP-9 were evaluated by the pathologist, who was blinded to all clinical data.
RESULTS: Transforming growth factor β1 expression positively correlated with MMP-9 expression (R = 0.4, P = 0.01). The expressions of TGF-β1 and MMP-9 were similar in subjects with POP versus controls. There was a significant increase in fibrous tissue (P = 0.008) and a corresponding decrease in smooth muscle (P = 0.03), associated with increasing age. The TGF-β1 expression, but not MMP-9 expression, also significantly increased with age (P = 0.02). DISCUSSION: Although our study uncovered age-related alterations in USL composition and TGF-β1 expression, there was no difference in the expression of TGF-β1 or MMP-9 in the subjects with POP versus controls.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25185601      PMCID: PMC4344824          DOI: 10.1097/SPV.0000000000000130

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  20 in total

1.  Increased matrix metalloproteinases-1,-9 in the uterosacral ligaments and vaginal tissue from women with pelvic organ prolapse.

Authors:  Michal Dviri; Elad Leron; Jacob Dreiher; Moshe Mazor; Ruthy Shaco-Levy
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-02-01       Impact factor: 2.435

2.  Lifetime risk of undergoing surgery for pelvic organ prolapse.

Authors:  Fiona J Smith; C D'Arcy J Holman; Rachael E Moorin; Nicolas Tsokos
Journal:  Obstet Gynecol       Date:  2010-11       Impact factor: 7.661

3.  Collagen metabolism in the uterosacral ligaments and vaginal skin of women with uterine prolapse.

Authors:  Christian H Phillips; Fred Anthony; Chris Benyon; Ash K Monga
Journal:  BJOG       Date:  2006-01       Impact factor: 6.531

4.  Increased expression of matrix metalloproteinase 2 in uterosacral ligaments is associated with pelvic organ prolapse.

Authors:  Boris Gabriel; Dirk Watermann; Katharina Hancke; Gerald Gitsch; Martin Werner; Clemens Tempfer; Axel zur Hausen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-12-08

5.  Expression of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinase-1 (TIMP-1, TIMP-2 and TIMP-3) in women with uterine prolapse but without urinary incontinence.

Authors:  Ching-Chung Liang; Hong-Yuan Huang; Ling-Hong Tseng; Shuenn-Dhy Chang; Tsia-Shu Lo; Chyi-Long Lee
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2010-08-03       Impact factor: 2.435

6.  Expression of transforming growth factor-beta 1 and connective tissue growth factor in women with pelvic organ prolapse.

Authors:  Xiao-Ying Qi; Li Hong; Feng-Qin Guo; Qiong Fu; Lu Chen; Bing-Shu Li
Journal:  Saudi Med J       Date:  2011-05       Impact factor: 1.484

7.  Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050.

Authors:  Jennifer M Wu; Andrew F Hundley; Rebekah G Fulton; Evan R Myers
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

8.  Nonobstetric risk factors for symptomatic pelvic organ prolapse.

Authors:  Ann Miedel; Gunilla Tegerstedt; Marianne Mæhle-Schmidt; Olof Nyrén; Margareta Hammarström
Journal:  Obstet Gynecol       Date:  2009-05       Impact factor: 7.661

Review 9.  Pulmonary fibrosis: pathogenesis, etiology and regulation.

Authors:  M S Wilson; T A Wynn
Journal:  Mucosal Immunol       Date:  2009-01-07       Impact factor: 7.313

10.  TGF-beta1 overexpression in the transversalis fascia of patients with direct inguinal hernia.

Authors:  G Pascual; C Corrales; V Gómez-Gil; J Buján; J M Bellón
Journal:  Eur J Clin Invest       Date:  2007-06       Impact factor: 4.686

View more
  4 in total

Review 1.  Mechanics of Uterosacral Ligaments: Current Knowledge, Existing Gaps, and Future Directions.

Authors:  Kandace Donaldson; Alyssa Huntington; Raffaella De Vita
Journal:  Ann Biomed Eng       Date:  2021-03-22       Impact factor: 3.934

2.  The role of transforming growth factor-ß (TGF-ß1) in postmenopausal women with pelvic organ prolapse: An immunohistochemical study.

Authors:  Greta Lisa Carlin; Klaus Bodner; Oliver Kimberger; Peter Haslinger; Christian Schneeberger; Reinhard Horvat; Heinz Kölbl; Wolfgang Umek; Barbara Bodner-Adler
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2020-05-11

3.  Molecular mechanism of extracellular matrix disorder in pelvic organ prolapses.

Authors:  Liping Zhang; Fangfang Dai; Gantao Chen; Yanqing Wang; Shiyi Liu; Li Zhang; Shu Xian; Mengqin Yuan; Dongyong Yang; Yajing Zheng; Zhimin Deng; Yanxiang Cheng; Xiaofeng Yang
Journal:  Mol Med Rep       Date:  2020-10-06       Impact factor: 2.952

4.  Expression of CD44, Transforming Growth Factor-β, and Matrix Metalloproteinases in Women With Pelvic Organ Prolapse.

Authors:  Weiwei Ying; Yanping Hu; Haibin Zhu
Journal:  Front Surg       Date:  2022-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.